Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
XLO —
XILIO THERAPEUTICS INC
CUSIP: 98422T100 · Held by 2 superinvestors · Combined value: $499,760
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $279,265 | 436,216 | NEW BUY | +436,216 |
| 2 | Jim Simons | 0.0% | $220,495 | 344,416 | ADD | +139,716 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | NEW BUY | +436,216 | New |
| Jim Simons | ADD | +139,716 | +68.3% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +40,500 | +24.7% |
Who Owns XLO? Superinvestor Holdings
XILIO THERAPEUTICS INC is held by 2 tracked superinvestors, with a combined position value of $499,760 . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.